Actavis Inc. Company Profile

09:59 EDT 25th June 2018 | BioPortfolio

Actavis Inc. is the U.S. subsidiary of Actavis Group hf. Approximately one third of Actavis' sales are generated in North America, Actavis' single largest market. Based in Morristown, NJ, Actavis has U.S. manufacturing facilities in Elizabeth, NJ and Lincolnton, NC. Actavis also has research and development facilities in Owings Mills, MD and Sunrise, FL.

News Articles [34 Associated News Articles listed on BioPortfolio]

English Court gives green light to Actavis for generic version of Alimta® in UK, France, Spain and Italy on basis of reconstitution in dextrose

Précis In a recent decision (Actavis & ors v Eli Lilly [2016] EWHC 234 (Pat)), the English High Court has granted declarations of non-infringement to Actavis, which was “clearing the ...

Celgene Settlement With Actavis Allows Abraxane Generics In 2022

Celgene settles Abraxane patent litigation and inter partes review with Teva's Actavis, allowing a generic to enter the market on...  

Actavis plc. rebrands on US Stock Exchange to Allergan plc.

Normal 0 false false false EN-GB X-NONE X-NONE Earlier this month, Actavis plc. announced that the company had adopted Allergan plc (NYSE: AGN) as its new global name.&nbs...

Pernix Announces Patent Litigation Settlement Agreement with Actavis Concerning Zohydro® ER

MORRISTOWN, N.J., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced that it has entered into a settlement agre...

Human medicines European public assessment report (EPAR): Desloratadine Actavis, desloratadine, Revision: 10, Authorised

Human medicines European public assessment report (EPAR): Imatinib Actavis, imatinib, Revision: 9, Authorised

Human medicines European public assessment report (EPAR): Telmisartan Actavis, telmisartan, Revision: 8, Authorised

Human medicines European public assessment report (EPAR): Sildenafil Actavis, sildenafil, Revision: 11, Authorised

PubMed Articles [0 Results]


Clinical Trials [15 Associated Clinical Trials listed on BioPortfolio]

A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fed Conditions

The purpose of this study is to compare the rate and extent of absorption of Actavis Group hf, Iceland, finasteride and Merck & Co. Inc., U.S.A. (Proscar), finasteride, administered as a 1...

Clinical Endpoint Study of Nepafenac 0.3% Opthalmic Suspension

A randomized, multicenter, double masked, placebo controlled, parallel group, bioequivalence study to evaluate the clinical equivalence and safety of Nepafenac 0.3% ophthalmic suspension (...

Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel

Marketed by Galderma Laboratories, L.P., Differin® (adapalene 0.3% topical gel) is a safe and effective topical therapy used for the treatment of acne vulgaris. Actavis Mid-Atlantic LLC h...

Clinical Endpoint Study of Ivermectin 0.5% Lotion

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence and Safety of Ivermectin Lotion 0.5% (Actavis Laborato...

Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris

Actavis has developed a generic formulation of clindamycin 1.2% and benzoyl peroxide 3.75% gel. This study is designed to evaluate the safety and efficacy of this formulation in subjects w...

Companies [6 Associated Companies listed on BioPortfolio]

Actavis Inc.

Actavis Inc. is the U.S. subsidiary of Actavis Group hf. Approximately one third of Actavis' sales are generated in North America, Actavis' single largest market. Based in Morristown, NJ, Actavis has ...

Actavis Group

Actavis is a fast growing company, headquartered in Iceland with modern development and manufacturing facilities in Europe, the U.S. and Asia and an extensive sales and marketing network in five conti...

The Actavis Group

Actavis' recent acquisition of the generics business of Alpharma positions the company among the five leading generic pharmaceutical companies in the world, with 10,000 employees in over 30 countries....

Forest Laboratories, Inc. and Furiex Pharmaceuticals, Inc.

Forest Laboratories (NYSE: FRX) is a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market. Forest markets a portfolio of branded...

Actavis plc and Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals (NASDAQ: IRWD) is focused on creating medicines that make a difference for patients, building value to earn the continued support of our fellow shareholde...

More Information about "Actavis Inc." on BioPortfolio

We have published hundreds of Actavis Inc. news stories on BioPortfolio along with dozens of Actavis Inc. Clinical Trials and PubMed Articles about Actavis Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Actavis Inc. Companies in our database. You can also find out about relevant Actavis Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Corporate Database Quicklinks

Searches Linking to this Company Record